What should be the next dose of metoprolol 50 mg orally for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metoprolol Dosing for Hypertension

For hypertension management, if blood pressure remains uncontrolled on metoprolol 50 mg, you should NOT simply increase the metoprolol dose—beta-blockers are not first-line agents for hypertension and the next step is to add or switch to preferred antihypertensive classes.

Key Clinical Decision Point

The 2020 ISH guidelines 1 and 2024 ESC guidelines 2 clearly establish that beta-blockers are NOT recommended as first-line therapy for essential hypertension. They are reserved for specific compelling indications (post-MI, heart failure with reduced ejection fraction, angina, or rate control) 3, 2.

Recommended Next Steps

If Patient is on Metoprolol 50 mg for Hypertension Alone:

The appropriate next step is to add or transition to first-line agents, NOT to increase metoprolol:

  1. Add an ACE inhibitor or ARB (first choice for non-Black patients) 1
  2. Add a dihydropyridine calcium channel blocker (CCB) 1, 2
  3. Add a thiazide or thiazide-like diuretic 1, 2

The 2020 ISH guidelines 1 recommend starting with low-dose ACE inhibitor/ARB, then adding a CCB or thiazide diuretic as the standard stepwise approach for non-Black patients. For Black patients, start with ARB plus CCB or CCB plus thiazide diuretic 1.

If Patient Has Compelling Indication for Beta-Blocker:

If the patient has post-MI, heart failure, or angina requiring beta-blocker therapy 4, 3, then:

  • Metoprolol tartrate can be titrated up to 100 mg twice daily (total 200 mg/day) 4, 5
  • Metoprolol succinate can be titrated to 200 mg once daily 4
  • However, still add first-line antihypertensive agents (ACE inhibitor/ARB, CCB, or thiazide) for blood pressure control 2

Important Caveats

Beta-Blocker Limitations in Hypertension:

  • Beta-blockers as monotherapy have inferior cardiovascular outcomes compared to ACE inhibitors, ARBs, CCBs, and diuretics 3, 6, 2
  • The 2024 ESC guidelines 2 explicitly state: "It is recommended that beta-blockers are combined with any of the other major BP-lowering drug classes when there are other compelling indications"
  • Avoid combining beta-blockers with thiazides as first choice due to increased diabetes risk 6

Dosing Considerations if Continuing Metoprolol:

From the FDA label 5:

  • Metoprolol tartrate: Start 25-50 mg every 6-12 hours, titrate to 100 mg twice daily (maximum 200 mg/day)
  • Metoprolol succinate: 50-200 mg once daily
  • Poor CYP2D6 metabolizers (8% of Caucasians) have several-fold higher plasma concentrations and require lower doses 5

Target Blood Pressure:

  • Target <130/80 mmHg for most patients 1
  • Target 120-129 mmHg systolic if well tolerated per 2025 AHA/ACC guidelines 7
  • Achieve target within 3 months 1

Practical Algorithm

  1. Assess if beta-blocker is truly indicated (post-MI, HFrEF, angina, rate control)
  2. If NO compelling indication: Add/switch to ACE inhibitor or ARB + CCB or thiazide
  3. If YES, compelling indication exists: Keep metoprolol AND add first-line agent
  4. Consider single-pill combinations to improve adherence 2
  5. Monitor response in 2-4 weeks and adjust accordingly 1

The evidence strongly supports that simply increasing metoprolol dose for uncomplicated hypertension is suboptimal therapy and does not align with current guideline-directed management.

Related Questions

A patient on metoprolol succinate 50 mg twice daily has blood pressure 146/92 mmHg and cannot take lisinopril; what additional antihypertensive medication should be added?
With blood pressure still elevated on metoprolol succinate 50 mg daily and a heart rate in the low 60s bpm, should I increase the metoprolol dose to 75 mg or add a second antihypertensive agent?
What points should be covered for a patient taking amlodipine and metoprolol as part of an MTM intervention?
How to adjust medication for a hypertensive patient with bradycardia taking amlodipine, losartan, and metoprolol succinate?
In an 82‑year‑old patient with a heart rate of 50 beats per minute while taking metoprolol 25 mg daily, should the metoprolol be held?
How should I manage a middle‑aged patient with moderate obstructive sleep apnea (apnea‑hypopnea index 27, nadir oxygen saturation 72%) who cannot tolerate continuous positive airway pressure, has frequent leg movements and restless‑leg symptoms improved by magnesium supplementation, normal ferritin, and is taking sertraline and lamotrigine?
How should I conduct and manage the preoperative physical examination?
In a 62‑year‑old hypertensive woman with normal aortic root and ascending aorta dimensions, mild concentric left‑ventricular hypertrophy, preserved left‑ventricular ejection fraction (61 %), grade I diastolic dysfunction (E/E′ ≈ 9), mild degenerative aortic valve calcification with mild aortic regurgitation, otherwise normal mitral, pulmonary and tricuspid valves, normal right‑sided chambers, estimated pulmonary pressures within normal limits, no thrombus or pericardial effusion, and an ECG showing sinus rhythm with a complete right‑bundle‑branch block and left‑anterior fascicular block (bifascicular block), what is the appropriate medical management?
How should valproate be offered to a 26‑year‑old woman of reproductive age with primary generalized tonic‑clonic seizures, considering its superior efficacy and teratogenic risks?
Can escitalopram be increased to 30 mg after a dose of 20 mg?
Can a psychiatric-mental health nurse practitioner (PMHNP) prescribe hormonal contraceptives?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.